selected publications
- The potency of hematopoietic stem cell reprogramming for changing immune tone. Immunological reviews. 2024 Review GET IT
- Microbial cancer immunotherapy reprograms hematopoietic stem cells to enhance anti-tumor immunity. 2024 GET IT
- Mechanisms of Epigenomic and Functional Convergence Between Glucocorticoid and IL4-Driven Macrophage Programming. 2024 GET IT
-
Epigenetic memory of coronavirus infection in innate immune cells and their progenitors.
Cell.
2023
Academic Article
GET IT
Times cited: 2 - Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment. Blood advances. 2022 Academic Article GET IT
-
Histone variant H3.3 maintains adult haematopoietic stem cell homeostasis by enforcing chromatin adaptability.
Nature cell biology.
2021
Academic Article
GET IT
Times cited: 16 -
A Fas-4-1BB fusion protein converts a death to a pro-survival signal and enhances T cell therapy.
The Journal of experimental medicine.
2020
Academic Article
GET IT
Times cited: 35 -
Histone H3.3 phosphorylation amplifies stimulation-induced transcription.
Nature.
2020
Academic Article
GET IT
Times cited: 78 -
A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia.
Blood.
2017
Academic Article
GET IT
Times cited: 42 -
Alternative Splice Transcripts for MHC Class I-like MICA Encode Novel NKG2D Ligands with Agonist or Antagonist Functions.
Journal of immunology (Baltimore, Md. : 1950).
2016
Academic Article
GET IT
Times cited: 3